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Intraoperative Computerized Decision Support Guidance 
Abstract 
Objectives: To compare postoperative nausea and vomiting (PONV) prophylaxis treatment and outcomes 
based on patients’ sex, using a retrospective cohort. The setting was the operating room and post-
anesthesia care unit of a tertiary care university medical center. 
Patients: A total of 678 adult male and female patients with American Society of Anesthesiologist (ASA) 
scores of 1-4 underwent surgery with general anesthesia. All patients received preoperative PONV risk 
assessment. PONV prophylaxis was administered at the discretion of the anesthesia care team members 
with guidance from a computerized decision support system. 
Measurements: Adequacy of prophylaxis was retrospectively determined based on individual patient risk 
factors and the observed treatment received, compared with guideline-based prophylaxis 
recommendations. Patient outcome was measured by diagnosis of PONV in recovery. 
Results: Comparing patients who received fewer than the guideline-recommended number of prophylactic 
antiemetics by sex, 94.6% were female and 5.4% were males (p < 0.001). Patients who received fewer 
than guideline-recommended number of antiemetics had significantly higher rates of nausea or vomiting 
in the post-anesthesia care unit (30.4% vs 17.5%, p < 0.001). 
Conclusion: This retrospective cohort study shows that female patients receiving general anesthesia are 
disproportionately affected by failure to adhere to PONV prevention guidelines. 
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Abstract
Objectives: To compare postoperative nausea 
and vomiting (PONV) prophylaxis treatment 
and outcomes based on patients’ sex, using 
a retrospective cohort. The setting was the 
operating room and post-anesthesia care unit 
of a tertiary care university medical center.
Patients: A total of 678 adult male and 
female patients with American Society 
of Anesthesiologist (ASA) scores of 1-4 
underwent surgery with general anesthesia. 
All patients received preoperative PONV 
risk assessment. PONV prophylaxis 
was administered at the discretion of the 
anesthesia care team members with guidance 
from a computerized decision support system.
Measurements: Adequacy of prophylaxis 
was retrospectively determined based 
on individual patient risk factors and the 
observed treatment received, compared 
with guideline-based prophylaxis 
recommendations. Patient outcome was 
measured by diagnosis of PONV in recovery.
Results: Comparing patients who received 
fewer than the guideline-recommended 
number of prophylactic antiemetics by sex, 
94.6% were female and 5.4% were males 
(p < 0.001). Patients who received fewer 








nausea or vomiting in the post-anesthesia care 
unit (30.4% vs 17.5%, p < 0.001).
Conclusion: This retrospective cohort study 
shows that female patients receiving general 
anesthesia are disproportionately affected 
by failure to adhere to PONV prevention 
guidelines.
Introduction
Postoperative nausea and vomiting (PONV) 
is a common complication associated with 
general anesthesia. Incidence of PONV is 
approximately 30% in the general population 
and up to 80% in high-risk individuals.1,2 
Postoperative vomiting increases risk of 
aspiration, pneumothorax, esophageal rupture 
and wound dehiscence.3,4 PONV may also 
lead to prolonged time in post-anesthesia 
care units (PACU), as well as unplanned 
admissions following ambulatory surgery.5,6,7 
From a patient satisfaction point of view, 
nausea and vomiting are reported as among 
the least desired outcomes following surgery.8 
Risk scores:Koivuranta et al. created an 



















to better predict a patients’ risk of PONV:1 
history of prior PONV or motion sickness, 
female sex, nonsmoker status, and anticipated 
postoperative opioid administration. In 
pediatrics, the Postoperative vomiting in 
Children (POVOC) score is most commonly 
used and does not take into consideration 
the sex of the patient, as sex does not change 
PONV risk in prepubescent children.9 
Female Sex as a Risk Factor: Female sex 
is the strongest clinical predictor of PONV, 
and female patients are 2-3 times more likely 







effects from pharmacological prophylaxis.11 
The exact mechanisms responsible for the 
increased incidence of PONV in females are 









phase, with the highest risk occurring during 
the follicular phase and lowest risk during 
the luteal phase.12,13,14 However, these results 
are inconsistent, with poor reproducibility 









predisposition towards nausea and vomiting.15 








on PONV prevention and treatment, 
pharmacologic prophylaxis rates are reported 
to be as low as 37% in moderate and high 
risk patients.1,16,17 To improve guideline 
adherence among clinicians, information 
technology solutions have been proposed, 
including electronic clinical decision support 









electronic medical record (EMR) to provide 
timely reminders and suggested treatments 
during episodes of care. At our institution, 
a CDSS is used to automatically calculate 
surgical patients’ Apfel risk score and prompt 
the anesthesia provider to administer PONV 
prophylaxis. Previous studies have reported 
that implementation of CDSS for PONV 
prevention has increased guideline adherence 
and lowered PONV incidence.18,19 Other 
successful CDSS integrations reported in 
anesthesia literature include intraoperative 
glucose monitoring, intraoperative blood 
pressure control and antibiotic administration 
less than 60 minutes prior to skin incision.20,21 
Academic Practice: While decision support 
tools can provide evidence-based prompts 
and treatment suggestions, patient care is 
ultimately under the control and clinical 
judgement of individual providers. In 
academic practices, the anesthesia care team 
is comprised of a variety of clinicians (e.g., 
physician anesthesiologists, nurse anesthetists 
and anesthesiology residents). This diversity 
of individuals, with different experience and 
training, can result in markedly different 
clinical care decisions. With respect to the 
management of PONV, personal preference 
and individual viewpoints of the clinician 
can affect adherence with published 
recommendations and guidelines. Despite 
published consensus recommendations and 
implementation of CDSS, we hypothesize that 
female patients are not receiving the same 
level of prophylaxis as males.
Methods
This retrospective study was approved by 
the University of Nebraska Medical Center 
(UNMC) Institutional Review Board (IRB). 
Informed consent for this retrospective study 
of existing EMR data was waived by the 
UNMC IRB. Records were obtained from 
consecutive, elective surgical procedures 
performed under general anesthesia on adult 
patients between January 2, 2017 and March 
31, 2017. Patients with incomplete or missing 
clinical data were excluded from analysis. 
UNMC is a tertiary-care teaching hospital that 
utilizes an anesthesia care team model. Care 










registered nurse anesthetists (CRNA) or 
anesthesiology residents. Preoperative 
screening, anesthetic technique planning, 
intraoperative management and post-
anesthesia care were at the discretion of the 
care team anesthesiologists, CRNAs and 
anesthesiology residents. 
Preoperative and post-anesthesia data were 
prospectively entered into the electronic 
medical record EPIC Systems software 
(Epic, Verona, WI) as a routine part of patient 
care. Intraoperative data were collected with 
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EPIC Anesthesia Information Management 
System (AIMS) in all facilities and operating 
rooms. Each patient received a preoperative 
assessment of their PONV risk within the 
EPIC EMR. The PONV assessment questions 
were retrospectively used to determine the 
prophylaxis level for each patient in the study. 
Prophylaxis levels were determined using the 
2014 consensus guidelines for PONV and 
are based on patients’ Apfel risk score.16 The 
following intraoperative prophylaxis treatment 
categories were then constructed (Table 1).
Intraoperative decision support was used to 
remind the anesthesia care team members 
of the patients’ risk and indication of PONV 
prophylaxis. The clinical decision support 
system utilized the data points acquired during 
the preoperative PONV risk assessment to 








suggests intraoperative administration of 
antiemetics for PONV prophylaxis. 









in the post-anesthesia care unit (PACU) 
requiring the administration of a rescue 
antiemetic medication. Antiemetics available 
to be used for either prophylaxis or rescue 
included ondansetron, diphenhydramine, 
lorazepam, prochlorperazine, promethazine, 
scopolamine, haloperidol, metoclopramide 
and dexamethasone. Choice of agent was 
at the discretion of the treating care team 
members.
Data retrieved from EPIC were analyzed 
using R statistical computing environment (R 
Core Team, 2019). Results are presented as 
number (percent) or mean (standard deviation) 
where appropriate. Chi-squared tests were 
used to compare categorical variables. 




A total of 747 adult patients were eligible for 
inclusion in the retrospective cohort. Of those, 









cohort size of 678 participants. Clinical 
demographics and PONV risk factors are 
presented in Table 2.
Treatment and Outcomes: The total 
incidence of PONV for all patients in the 







93.2% of the low risk group receiving 
more pharmacologic prophylaxis than 
recommended by guidelines. Conversely, 
85.7% of patients in the high risk group 
received fewer agents than consensus 
guidelines suggest (p < 0.001). Patients 
in the moderate risk group received the 
guideline-recommended number of antiemetic 








across prophylaxis categories. Among patients 
who were considered inadequate prophylaxis, 
30.4% required treatment for PONV while 
in the recovery area (Table 4). In contrast, 
patients who received adequate prophylaxis or 
excessive prophylaxis were treated for PONV 
in 17.5% and 13.5% of cases, respectively (p 
< 0.001).




















higher rates than male patients (58.4% vs. 
4.5%, respectively, p < 0.001). Of patients 
receiving fewer prophylaxis medications than 
guidelines recommend, 94.6% were female 
(Table 6 and Figure 1). Female patients also 










than the 11.8% observed among male patients 








female patients. Females had a higher rate 
of prior PONV or motion sickness history, 
21.6%, compared to 4.5% among male 






more frequently than did male patients (73.5% 








between female and male patients. Recovery 
times in PACU were similar between males 
and females. 
Discussion
In this retrospective cohort study, we 
report that PONV prophylaxis failure 
disproportionately affects female patients 
undergoing surgery requiring general 
anesthesia. As a group, the majority of 
female patients, 58.4%, were administered 
fewer than the guideline-recommended 
number antiemetics to prevent PONV. In 
contrast, only 4.5% of male patients received 
fewer than the recommended number of 
















(1 or 2 Risk Factors)
High
(3+ Risk Factors)
None Adequate Under Under
1 or 2 Over Adequate Under
3+ Over Over Adequate
Table 2. 




Mean (SD) 54.47 (16.25)
BMI

























Low (Apfel 0-1) 147 (21.7%)
Moderate (Apfel 2) 259 (38.2%)
High (Apfel 3-4) 272 (40.1%)
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the under-prophylaxed group, making up 
94.6% of the patient total. In addition, the 
corresponding rates of nausea or vomiting 
requiring treatment among female patients 
was more than twice that observed among 
male patients (28.0% vs. 11.8%). The overall 
observed rate of PONV within the cohort was 
21.1%, slightly lower than that reported in the 
general population.16,22 
Female patients’ predisposition towards 
PONV has been well established, as female 
sex is the strongest reported risk factor for 
the development of postoperative nausea and 
vomiting.10 In this cohort, female patients 
also had higher rates of two other PONV 
risk factors, namely prior history of PONV/
motion sickness and postoperative opioid 
administration. Our study also highlights 







in the high-risk patients, who were under 
prophylaxis in 87.5% of cases. This failure 
to adhere to PONV prevention guidelines 







designed to address PONV risk factors during 
intraoperative patient care. 
Investigating the effectiveness of CDSS 
for PONV prophylaxis compliance was 
outside the scope of this study. A report by 
Kooij et al., however, described increased 







risk patients.18 In their study, CDSS was 
limited to the preoperative screening clinic 
and was not in the setting of the operating 
room environment. Gabel et al. extended the 
use of clinical decision support technology by 
incorporating preoperative decision support, 
intraoperative checklists and personalized 
email reports to achieve of reduction in PONV 








to affect improvements in adherence with 
PONV consensus guidelines. 
Our study has several limitations. The clinical 
data gathered to calculate risk scores were 
dependent on the accuracy of preoperative 
assessments. Information bias, in which 
patients selectively or inconsistently recall 
details, could cause patients to inadvertently 
misrepresent their actual PONV risk. 
Inaccurate PONV risk assessments affect not 
only individual clinician’s treatment decisions 
but also the CDSS results and prompts. 
Because this was an observational study, not 








to the calculated Apfel PONV risk score 
Table 3. 







Risk Category < 0.001
Under prophylaxis 0 (0%) 7 (2.7%) 233 (85.7%)
Adequate prophylaxis 10 (6.8%) 226 (87.3%) 39 (14.3%)
Over prophylaxis 137 (93.2%) 26 (10.0%) 0 (0%)
Table 4. 







PONV in Recovery < 0.001
No PONV 167 (69.6%) 227 (82.5%) 141 (86.5%)
PONV 73 (30.4%) 48 (17.5%) 22 (13.5%)









Female 227 (94.6%) 132 (48.0%) 30 (18.4%)
Male 13 (5.4%) 143 (52.0%) 133 (81.6%)







Current Smoker 65 (16.7%) 54 (18.7%)
Nonsmoker 324 (83.3%) 235 (81.3%)
Postoperative Opioids 0.010
No 103 (26.5%) 103 (35.6%)
Yes 286 (73.5%) 186 (64.4%)
History of PONV < 0.001
No 305 (78.4%) 276 (95.5%)
Yes 84 (21.6%) 13 (4.5%)
Level of prophylaxis < 0.001
Under prophylaxis 227 (58.4%) 13 (4.5%)
Adequate prophylaxis 132 (33.9%) 143 (49.5%)
Over prophylaxis 30 (7.7%) 133 (46.0%)
PONV in recovery < 0.001
No PONV 280 (72.0%) 255 (88.2%)
PONV 109 (28.0%) 34 (11.8%)
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or mandatory reaction to the prompts and 
reminders provided by the CDSS.
We report that female patients are 
disproportionately affected by failure to 
adhere to PONV prevention and treatment 
guidelines. Furthermore, this disparity was 
particularly glaring in an environment where 
CDSS technology was employed to identify 
patients with multiple PONV risk factors for 
immediate treatment by an anesthesia care 
team. Future investigations will be needed 
to elucidate underlying causes for deviation 
from PONV prophylaxis guidelines by 
individual practitioners and for the systematic 
undertreatment of PONV in female patients. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.091 
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